Cantitate/Preț
Produs
Total produse
Vezi coșul
New Drugs, Concepts and Results in Cancer Chemotherapy de Franco M. Muggia

New Drugs, Concepts and Results in Cancer Chemotherapy: Cancer Treatment and Research, cartea 58

Editat de Franco M. Muggia
en Limba Engleză Hardback – 31 oct 1991

Toate formatele și edițiile

Toate formatele și edițiile Preț Express
Paperback (1) 108787 lei  6-8 săpt.
  Springer Us – 24 sep 2012 108787 lei  6-8 săpt.
Hardback (1) 109573 lei  6-8 săpt.
  Springer Us – 31 oct 1991 109573 lei  6-8 săpt.

Din seria Cancer Treatment and Research

  • 5% T-Cell and NK-Cell Lymphomas: From Biology to Novel Therapies
    Preț: 110303 lei
  • 5% HIV/AIDS-Associated Viral Oncogenesis
    Preț: 72632 lei
  • 5% Tumor Microenvironment
    Preț: 78758 lei
  • 5% Cancer Immunotherapies: Solid Tumors and Hematologic Malignancies
    Preț: 103793 lei
  • 5% Cancer Drug Safety and Public Health Policy: A Changing Landscape
    Preț: 103264 lei
  • 5% Therapeutic Approaches in Cancer Treatment
    Preț: 104177 lei
  • 5% Targeting the DNA Damage Response for Cancer Therapy
    Preț: 91742 lei
  • 5% Threshold Decision-making in Clinical Medicine: With Practical Application to Hematology and Oncology
    Preț: 71902 lei
  • 5% Epigenetics in Oncology
    Preț: 92018 lei
  • 5% Hodgkin’s Disease in Children: Controversies and Current Practice
    Preț: 47291 lei
  • 5% Molecular Genetics and Therapy of Leukemia
    Preț: 65184 lei
  • 5% Surgical Oncology
    Preț: 49135 lei
  • 5% Adrenal and Endocrine Tumors in Children: Adrenal Cortical Carcinoma and Multiple Endocrine Neoplasia
    Preț: 72119 lei
  • 5% Lung Cancer 1
    Preț: 37038 lei
  • 15% Bayesian Methods in Reliability
    Preț: 70010 lei
  • 5% Gynecologic Oncology
    Preț: 211684 lei
  • 5% Palliative Care and Rehabilitation of Cancer Patients
    Preț: 141408 lei
  • 5% Advances in Allogeneic Hematopoietic Stem Cell Transplantation
    Preț: 142416 lei
  • 5% HIV & HTLV-I Associated Malignancies
    Preț: 110669 lei
  • 5% Thoracic Oncology
    Preț: 129762 lei
  • 5% Cancer Chemoprevention
    Preț: 110322 lei
  • 5% Myelodysplastic Syndromes & Secondary Acute Myelogenous Leukemia: Directions for the New Millennium
    Preț: 109444 lei
  • 5% Liver-Directed Therapy for Primary and Metastatic Liver Tumors
    Preț: 109645 lei
  • 5% Biology and Management of Lung Cancer
    Preț: 141356 lei
  • 5% Non-Myeloablative Allogeneic Transplantation
    Preț: 72010 lei
  • 5% Atlas of Selective Sentinel Lymphadenectomy for Melanoma, Breast Cancer and Colon Cancer
    Preț: 70677 lei
  • 5% Clinically Relevant Resistance in Cancer Chemotherapy
    Preț: 73107 lei
  • 5% Biostatistical Applications in Cancer Research
    Preț: 141480 lei
  • 5% Head and Neck Cancer
    Preț: 110872 lei
  • 5% Signal Transduction in Cancer
    Preț: 109812 lei
  • 5% Kidney Cancer
    Preț: 109222 lei
  • 5% Angiogenesis in Brain Tumors
    Preț: 109956 lei
  • 5% The Biology of Skeletal Metastases
    Preț: 110633 lei

Preț: 109573 lei

Preț vechi: 115339 lei
-5% Nou

Puncte Express: 1644
Preț estimativ în valută:
20972€ • 21613$ • 17706£

Carte tipărită la comandă

Livrare economică 01-15 martie

 Adaugă în coș

Wish list
Gift list
Am citit!
Adaugă în listă
Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9780792312536
ISBN-10: 0792312538
Pagini: 165
Ilustrații: XIII, 165 p.
Dimensiuni: 155 x 235 x 16 mm
Greutate: 0.45 kg
Ediția:1991
Editura: Springer Us
Colecția Springer
Seria Cancer Treatment and Research

Locul publicării:New York, NY, United States

Public țintă

Research

Cuprins

I. Concepts.- 1. Pharmacologic control of specific gene expression.- 2. Modulation of the activity of cancer chemotherapeutic agents by dipyridamole.- II. New drugs and modifiers.- 3. Pharmacology and clinical investigation of SR-2508 (etanidazole).- 4. Folate antimetabolites inhibitory to de novo purine synthesis.- 5. Taxol: A new agent active in melanoma and ovarian cancer.- 6. ICRF-187 (ADR-529) cardioprotection against anthracycline-induced cardiotoxicity: Clinical and preclinical studies.- 7. Uroprotection in patients receiving cyclophosphamide and ifosfamide.- III. Disease targets.- 8. The role of progesterone receptors in meningioma.- 9. Combined chemotherapy and radiotherapy in small-cell lung cancer.- Addendum to Chapter 2.